A kidney cancer vaccine candidate has shown great promise in an early Phase I trial published this week.
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
Related Posts
Google is inserting itself in newsrooms with the promotion of…
U.S. manufacturing takes up a lot of energy, but there’s…